Accolades: Awards, honors and accomplishments October
October 19, 2026
Congratulations to Oleg Varlamov, Aaron Grossberg, Jennifer Huang, David Huang, Erik Brodt, Justin Merritt, the PEACE team, Hyunjee Kim, Amy Edmonds, Lucia Carbone, Duncan Ramsey, Pacific Northwest Evidence-based Practice Center, Eric Roeland, Kerri Winters Stone, Jessica Reid, Paula Amato, Jamie Lo, Ashley Benson, Joseph Shatzel, Motoyuki Tsuda, Kareem Woods and William Hersh.
OHSU researchers explore link between gut, brain health for people with HIV
October 13, 2026
$5.8 million award from NIH could lead to new therapies to address harmful inflammation.
Cancer cells use antioxidant protein to suppress T cells, resist immunotherapy, study finds
September 03, 2026
OHSU co-author helps identify potential therapeutic target in tumors that evade the immune system.
Accolades: Awards, honors and appointments July
July 20, 2026
Congratulations to James Frank, Megan Ruhland, Matt Chan, Andrew Wang, OHSU Family Medicine Interest Group, Erick Turner, Xiaolin Nan, Nadine Mallak, Emily Van Houweling, Eric Lau, Nathan Pennock, Steven Mansoor, Lucia Carbone, Emily Voigt, Caralyn Labriola, Jacob Estes, Michael Axthelm, Brandon Wilder, Claudio Mello lab, Michael Harris, Katelyn Byrne, Greagory Baker, Erin Kenzie, Melissa Wong, Logan Jones, Taylor Anderson and Jeff Gold.
Developing targeted therapies to treat pediatric brain injury
May 06, 2026
Manideep Chavali, Ph.D., works to better understand neurodevelopment, brain disorders in children.
Project seeks to develop retinal screening for Alzheimer’s
January 27, 2026
OHSU biomedical engineer and imaging scientist awarded federal funding for high-risk, high-reward project.
Knight Cancer Group hires new CEO
January 26, 2026
Joel Helmke, M.H.A., has been selected to serve as chief executive officer of the Knight Cancer Group.